Mike Spadafore is listed as a director on 3 SEC Form D filings by 2 issuers between Jun 2020 and May 2024: Abacus Insights, Inc. (Boston, MA — other technology — 2020–2022; $40.9M reported sold to 14 investors) and ATROPOS HEALTH INC (New York, NY — other health care — 2024; $33M reported sold to 16 investors).
What this means 2 separate companies raised money with this person listed as director, over about 4 years. Across those companies the filings report $73.9M sold in total.
Listed alongside Graham Brooks (2 shared filings), Minalkumar Patel (2 shared filings), Brigham Hyde (1 shared filing), Matthew Bettonville (1 shared filing), Neil Sanghavi (1 shared filing) and 2 others.
What this means These are the other officers, directors or promoters the companies named on the same forms — the team around Mike. Each name links to their own page.
Public records searched: federal courts (CourtListener / RECAP), SEC enforcement releases, state securities regulators (AZ, CA, DE, TX, WA) — none found.
What this means Nothing turned up where we looked (3 sources). That does not prove there is nothing — it means none was found in those sources on that date.
We compared 3 public filings for Mike Spadafore and found 7 differences, 1 worth asking the sponsor about: Mike Spadafore is no longer listed on the May 1, 2024 amendment; and more below.
What this means These are differences between the sponsor's own SEC filings — both values, dates and sources are listed in Key records, section 4. Most have ordinary explanations; ask the sponsor.